Fatigue Some patients experience fatigue, particularly during dose titration
The appropriate response depends on the severity and frequency of symptoms
Learn more: In 2025, the American College of Lifestyle Medicine joined the American Society for Nutrition (ASN), the Obesity Medicine Association (OMA), and The Obesity Society (TOS) to release the joint clinical advisory Nutritional Priorities to Support GLP-1 Therapy for Obesity. Dr
Consult Your Healthcare Provider : If youre unsure when to take your next dose or missed multiple doses, its best to consult your healthcare provider
Outcomes Primary outcome measures were selected based on available vital and lab measurements that would capture the intended impact of GLP-1s especially for diabetic or obese patients, as at the time of this study, GLP-1 use had primarily been approved as therapy to improve glycemic control and support weight loss
Product Information Reviews Review Graph 5 star 0% 4 star 0% 3 star 0% 2 star 0% 1 star 0% * Muscle & Strength does not imply any medical claims from this review
